StockData
Ceribell, Inc. logo

Ceribell, Inc. (CBLL) income statement

CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$25.63−0.34 (-1.31%)

Close on Nov 18, 2026Market cap $983.63MP/E –Yield –

Ceribell, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
88.9%
Operating margin
-68.6%
Net margin
-64.7%
Return on equity, FY2025
-30.8%

Financial strength

Current ratio
9.18
Debt to equity
0.16
Debt to assets
12.0%
Cash to current liabilities
189.9%

Valuation

P/E ratio
–
Price to sales
9.65
Price to book
7.67
Dividend yield
–

See a number that looks wrong?